Newsroom

Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor, sotorasib

This biomarker may help physicians determine those most likely to benefit from sotorasib and those who may need alternative or combination therapies

TTF-1 is a readily available biomarker commonly used for lung cancer diagnostics

Researchers from The University of Texas...